The Latest
-
FDA issues early alert on Trividia glucometer issue linked to 114 injuries
Users may receive an error code either due to a test strip error or a very high blood glucose event, Trividia Health said.
-
Medtronic nets FDA clearance for robotic spine system
Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes market share in the $15 billion cranial and spinal technologies sector.
-
Federal judge strikes down FTC rule expanding premerger reporting requirements
The regulation required firms to provide more details ahead of mergers, likely chilling dealmaking. The Federal Trade Commission could appeal the ruling.
-
Danaher to buy Masimo for $9.9B to boost diagnostics portfolio
Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient monitoring company said.
-
GE HealthCare, BARDA ink $35M expansion to AI-enabled imaging deal
The jointly funded project positions GE HealthCare to develop ultrasound technologies that non-expert users can operate.
-
Medline addresses bed fire risk linked to death
The FDA said hand pendants and cords may overheat, causing the devices to spark, burn, melt, smoke and catch fire.
-
Medtronic completes first Hugo case in the US
CEO Geoff Martha said that while Hugo may not “move the needle” for Medtronic’s surgical business yet, the system is growing “pretty fast.”
-
Novocure wins FDA approval to treat pancreatic cancer with electric fields
Winning approval to target the 15,000 U.S. patients with locally advanced pancreatic cancer is the first step in a broader expansion in the tumor type.
-
Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
-
HHS elevates officials into Kennedy’s inner circle in advance of midterms
The HHS secretary has four new senior advisors to help him “move faster and go further” on his Make America Healthy Again agenda. The appointments preempt the GOP’s midterm messaging push.
-
Siemens Healthineers, Mayo Clinic partner on neurodegenerative disease, cancer
An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to certain neurological disorders.
-
Neurent raises $74M to commercialize treatment for nasal condition
The device creates lesions to disrupt nerve signals that drive mucus production.
-
AdvaMed names Melissa Torres as new leader for technology and regulatory affairs
Torres joins the medtech lobby from the FDA’s Center for Devices and Radiological Health, where she was associate director for international affairs.
-
Zimmer plans US salesforce reorganization
Zimmer Biomet expects the shift of its U.S. salesforce to a more specialized, direct approach will help it better compete in the orthopedics market.
-
CDC moves to cut $600M in grants to Democrat-led states
The cut grants, which were viewed by Healthcare Dive, fund a wide swath of areas including workforce initiatives, STI prevention measures, health equity proposals and others in California, Colorado, Illinois and Minnesota.
-
Edwards focuses on earlier TAVR adoption
The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.
-
4 takeaways from the 2026 AF Symposium
Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.
-
Labcorp closes takeover of Empire City assets to fuel New York expansion
The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.
-
Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene
Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.
-
Stryker starts limited release of Mako RPS handheld knee robot
Surgeons interested in robotic technology but wanting a simpler system than existing platforms are the target market for the new device.
-
Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine
Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.
-
FDA breakthrough program starts FY2026 at steady pace
Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.
-
AI in medtech is booming. Track new devices here.
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.
Updated Feb. 9, 2026 -
J&J recalls coil systems used in aneurysm treatment
Healthcare providers are advised to stop using the devices after a failure to detach was linked with four serious injuries and one death.
-
GE HealthCare expects smaller tariff impact in 2026
After taking a $245 million hit from the levies in 2025, CFO James Saccaro said the company plans more actions to mitigate their effects in 2026, including shifting its supply chain.